This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lorentzon, M. Articles by Ohlsson, C. Search for Related Content PubMed PubMed Citation Articles by Lorentzon, M. Articles by Ohlsson, C. Related Collections Calcium and Bone Metabolism

Smoking Is Associated with Lower Bone Mineral Density and Reduced Cortical Thickness in Young Men

Center for Bone Research at the Sahlgrenska Academy (CBS) (M.L., D.M., C.O.), Department of Internal Medicine, Gothenburg University, 413 45 Gothenburg, Sweden; and Hormone Laboratory (E.H.), Aker University Hospital, N-0514 Oslo, Norway

Address all correspondence and requests for reprints to: Mattias Lorentzon, M.D., Ph.D., Division of Endocrinology, Department of Internal Medicine, Gröna Stråket 8, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden. E-mail: mattias.lorentzon{at}medic.gu.se.

Context: Smoking has previously been associated with reduced areal bone mineral density (aBMD) in elderly subjects, but the association remains controversial in adolescents.

Objective: The aim of this study was to determine whether smoking was associated with aBMD or volumetric BMD (vBMD) and bone size in young men.

Design and Setting: aBMD was measured using dual x-ray absorptiometry. vBMD and bone size were measured using peripheral quantitative computerized tomography (pQCT). Smoking habits were assessed using questionnaires. Levels of sex steroids, PTH, and 25-OH-vitamin D were measured in serum.

Participants: The population-based Gothenburg Osteoporosis and Obesity Determinants (GOOD) study includes 1068 young men, age 18.9 ± 0.6 yr (mean ± SD).

Main Outcome Measure: The main outcome measure was smoking as predictor of bone parameters and serum sex hormone levels.

Results: Of the study subjects, 8.7% smoked daily. Bone parameters were compared between smokers and nonsmokers. Smokers had significantly lower aBMD (dual x-ray absorptiometry) of the total body (crude: –2.1%; adjusted for age, height, weight, calcium intake, and physical activity: –1.8%), lumbar spine (crude: –4.3%; adjusted: –3.3%), and trochanter (crude: –6.6%; adjusted: –5.0%) than nonsmokers. Using peripheral quantitative computerized tomography, we found that smokers had lower cortical thickness of both the radius (crude: –2.8%; adjusted: –2.9%) and tibia (crude: –4.5%; adjusted: –4.0%) than the nonsmokers, whereas no difference was seen for cortical vBMD. Smokers had higher serum levels of total and free testosterone and lower 25-OH-vitamin D than nonsmokers. Adjustment for testosterone and/or 25-OH-vitamin D levels did not alter the associations between smoking and bone parameters.

Conclusions: We demonstrate that smoking was associated with lower aBMD and reduced cortical thickness in young men.

This article has been cited by other articles:

				I. Bab and R. Yirmiya Depression, Selective Serotonin Re-Uptake Inhibitors and the Regulation of Bone Mass IBMS BoneKEy, January 1, 2009; 6(1): 8 - 15. [Abstract] [Full Text] [PDF]

				M. Sneve, N. Emaus, R. M. Joakimsen, and R. Jorde The association between serum parathyroid hormone and bone mineral density, and the impact of smoking: the Tromso Study Eur. J. Endocrinol., March 1, 2008; 158(3): 401 - 409. [Abstract] [Full Text] [PDF]

				J. Compston Smoking and the Skeleton J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 428 - 429. [Full Text] [PDF]